title: [Intravitreal dexamethasone as an enhancer for the anti-VEGF treatment in neovascular ARMD: recovering an old ally].
authors.forename: R
authors.initials: R
authors.lastname: Gallego-Pinazo
authors.forename: C
authors.initials: C
authors.lastname: Marín-Lambíes
authors.forename: F
authors.initials: F
authors.lastname: Marín-Olmos
authors.forename: R
authors.initials: R
authors.lastname: Martínez
authors.forename: R
authors.initials: R
authors.lastname: Fons
authors.forename: M L
authors.initials: ML
authors.lastname: Díaz-Llopis
authors.forename: M L
authors.initials: ML
authors.lastname: Díaz-Llopis
authors.forename: M L
authors.initials: ML
authors.lastname: Díaz-Llopis
mesh_terms: D020256:Choroidal Neovascularization / Q000150:complications / Q000188:drug therapy*; D003907:Dexamethasone / Q000008:administration & dosage*; D006801:Humans; D058449:Intravitreal Injections; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D057135:Wet Macular Degeneration / Q000150:complications / Q000188:drug therapy*
chemical_list: D042461:Vascular Endothelial Growth Factor A; D003907:Dexamethasone